These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1848335)

  • 1. Effect of the somatostatin analogue octreotide acetate on hemostasis in humans.
    Witzig TE; Kvols LK; Moertel CG; Bowie EJ
    Mayo Clin Proc; 1991 Mar; 66(3):283-6. PubMed ID: 1848335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. A study by the Italian Trials in Medical Oncology Group.
    di Bartolomeo M; Bajetta E; Buzzoni R; Mariani L; Carnaghi C; Somma L; Zilembo N; di Leo A
    Cancer; 1996 Jan; 77(2):402-8. PubMed ID: 8625251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of somatostatin on hemostasis in baboons.
    Koerker DJ; Harker LA; Goodner CJ
    N Engl J Med; 1975 Sep; 293(10):476-9. PubMed ID: 1152861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours.
    Arnold R; Trautmann ME; Creutzfeldt W; Benning R; Benning M; Neuhaus C; Jürgensen R; Stein K; Schäfer H; Bruns C; Dennler HJ
    Gut; 1996 Mar; 38(3):430-8. PubMed ID: 8675099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and morbidity of cholelithiasis in patients receiving chronic octreotide for metastatic carcinoid and malignant islet cell tumors.
    Trendle MC; Moertel CG; Kvols LK
    Cancer; 1997 Feb; 79(4):830-4. PubMed ID: 9024721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Octreotide, a new somatostatin analogue.
    Katz MD; Erstad BL
    Clin Pharm; 1989 Apr; 8(4):255-73. PubMed ID: 2653711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin-induced changes in the hemostasis of rats.
    Long MW; Micossi P; Pontiroli AE; Dunbar JC; Foà PP; Henry RL
    Thromb Haemost; 1979 May; 41(3):601-7. PubMed ID: 462425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin analog sandostatin and inhibition of tumor growth in patients with metastatic endocrine gastroenteropancreatic tumors.
    Arnold R; Neuhaus C; Benning R; Schwerk WB; Trautmann ME; Joseph K; Bruns C
    World J Surg; 1993; 17(4):511-9. PubMed ID: 8395752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of aspirin on platelets and the bleeding time.
    Mielke CH
    Am J Med; 1983 Jun; 74(6A):72-8. PubMed ID: 6344629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas.
    Reubi JC; Kvols LK; Waser B; Nagorney DM; Heitz PU; Charboneau JW; Reading CC; Moertel C
    Cancer Res; 1990 Sep; 50(18):5969-77. PubMed ID: 2168286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of the long-acting somatostatin analogue, octreotide acetate, in patients with islet cell tumors.
    Maton PN
    Gastroenterol Clin North Am; 1989 Dec; 18(4):897-922. PubMed ID: 2559036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of somatostatin on coagulation and platelet function in man.
    Mielke CH; Gerich JE; Lorenzi M; Tsalikian E; Rodvien R; Forsham PH
    N Engl J Med; 1975 Sep; 293(10):480-3. PubMed ID: 1152862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation studies and platelet function after somatostatin infusion.
    Rasche H; Raptis S; Scheck R; Pfeiffer EF
    Klin Wochenschr; 1976 Oct; 54(20):977-82. PubMed ID: 979078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the somatostatin analogue octreotide acetate in the treatment of encephalopathy associated with carcinoid tumor. Case report.
    Siu LL; Chapman W; Moore MJ
    Am J Clin Oncol; 1997 Dec; 20(6):558-61. PubMed ID: 9391539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of octreotide acetate for control of symptoms in patients with islet cell tumors.
    Maton PN
    World J Surg; 1993; 17(4):504-10. PubMed ID: 8395751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Somatostatin analogue in the treatment of neuroendocrine gut tumors].
    Ben Yosef R; Glaser B; Catane R
    Harefuah; 1990 Jul; 119(1-2):15-8. PubMed ID: 2172125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An important new treatment for carcinoid tumors and VIPomas.
    Oncology (Williston Park); 1988 Dec; 2(12):35-6. PubMed ID: 2856315
    [No Abstract]   [Full Text] [Related]  

  • 18. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of somatostatin analogue (octreotide) on blood flow to endocrine tumors metastatic to the liver: angiographic evaluation.
    Cho KJ; Vinik AI
    Radiology; 1990 Nov; 177(2):549-53. PubMed ID: 2171015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival in a patient with malignant carcinoid treated with high-dose octreotide.
    Deguchi H; Deguchi K; Tsukada T; Murashima S; Iwasaki E; Tsuda M; Kobayashi T; Shirakawa S
    Intern Med; 1994 Feb; 33(2):100-2. PubMed ID: 7517229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.